Syschem (India) Ltd

₹ 29.8 0.20%

18 Sep - close price

About

Incorporated in 1993, Syschem (India) Limited manufactures Active Pharmaceuticals Ingredients (APIs) and bulk drugs.^[1]

Key Points

Product Profile:^[1]
API/ Intermediates:
** a) Amoxycillin Trihydrate
b) Ampicillin Trihydrate
c) Cloxacillin Sodium
d) Dicloxacillin Sodium
e) Flucloxacillin Sodium (For export only)
f) Cephalexin
g) Cefadroxil
h) **Distillation of Specialist Solvents – methonel, Acetonitrile, Ethyl Acetate, and THF

Website BSE

Market Cap ₹ 160 Cr.
Current Price ₹ 29.8
High / Low ₹ 61.0 / 28.8
Stock P/E 26.0
Book Value ₹ 25.0
Dividend Yield 0.00 %
ROCE 15.9 %
ROE 10.2 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Stock is trading at 1.19 times its book value
Company is expected to give good quarter
Company has delivered good profit growth of 32.4% CAGR over last 5 years
Promoter holding has increased by 2.52% over last quarter.
Company's median sales growth is 70.0% of last 10 years
Company's working capital requirements have reduced from 40.8 days to 29.3 days

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has a low return on equity of 6.41% over last 3 years.
Contingent liabilities of Rs.50.2 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	43.10	37.11	43.74	74.71	87.53	47.52	77.76	118.87	109.32	103.60	141.50	219.35	109.21
	40.65	35.26	42.66	73.09	86.72	47.45	76.56	116.97	106.86	100.30	135.54	209.98	108.67
Operating Profit	2.45	1.85	1.08	1.62	0.81	0.07	1.20	1.90	2.46	3.30	5.96	9.37	0.54
OPM %	5.68%	4.99%	2.47%	2.17%	0.93%	0.15%	1.54%	1.60%	2.25%	3.19%	4.21%	4.27%	0.49%
	0.00	0.00	0.01	0.15	0.01	0.00	0.02	0.02	0.01	0.01	0.00	0.00	0.05
Interest	0.10	0.03	0.11	0.01	0.00	0.03	0.04	0.00	0.04	0.01	0.17	2.04	0.49
Depreciation	0.68	0.70	0.74	0.67	0.68	0.68	0.68	0.91	0.76	0.76	0.82	1.73	1.56
Profit before tax	1.67	1.12	0.24	1.09	0.14	-0.64	0.50	1.01	1.67	2.54	4.97	5.60	-1.46
Tax %	0.00%	0.00%	0.00%	123.85%	0.00%	0.00%	0.00%	54.46%	0.00%	25.59%	15.90%	68.93%	15.07%
	1.68	1.12	0.23	-0.26	0.14	-0.64	0.50	0.46	1.67	1.90	4.17	1.74	-1.67
EPS in Rs	0.42	0.28	0.06	-0.07	0.04	-0.16	0.13	0.11	0.38	0.44	0.96	0.36	-0.34
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	11	4	13	67	93	77	68	59	114	199	332	574	574
	14	5	12	63	89	77	73	58	105	192	328	553	554
Operating Profit	-3	-1	0	3	4	-0	-5	1	9	7	4	21	19
OPM %	-23%	-24%	0.4%	4.5%	4.4%	-0.1%	-7%	0.9%	8%	3.5%	1.2%	3.7%	3.3%
	0	0	-0	-0	-0	0	-0	0	0	0	0	0	0
Interest	1	0	0	0	0	0	0	0	0	0	0	2	3
Depreciation	2	2	2	2	2	2	2	3	3	3	3	4	5
Profit before tax	-5	-3	-2	1	2	-2	-7	-2	6	4	1	15	12
Tax %	-26%	-27%	-30%	43%	50%	-16%	-24%	-22%	27%	33%	54%	26%
	-4	-2	-1	0	1	-2	-6	-2	5	3	0	11	6
EPS in Rs	-1.94	-1.13	-0.75	0.17	0.32	-0.79	-2.07	-0.59	1.13	0.69	0.11	2.23	1.42
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	66%
5 Years:	53%
3 Years:	72%
TTM:	62%

Compounded Profit Growth
10 Years:	21%
5 Years:	32%
3 Years:	34%
TTM:	209%

Stock Price CAGR
10 Years:	18%
5 Years:	27%
3 Years:	-18%
1 Year:	-46%

Return on Equity
10 Years:	4%
5 Years:	7%
3 Years:	6%
Last Year:	10%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	16	16	19	19	22	23	32	40	44	49
Reserves	-6	-8	-10	-8	-8	-10	-15	-16	-10	17	48	73
	28	27	22	20	16	17	16	2	2	0	0	0
	13	12	16	29	35	36	55	51	69	107	126	169
Total Liabilities	51	47	44	58	62	62	77	60	93	164	217	292
	34	32	30	29	27	28	30	32	31	31	53	68
CWIP	1	1	1	0	0	1	1	0	0	4	0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0
	16	15	14	28	35	34	46	28	62	129	164	224
Total Assets	51	47	44	58	62	62	77	60	93	164	217	292

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1	0	6	0	-2	3	4	1	-8	-26	-10	8
	0	0	0	0	2	-4	-4	-1	-2	-6	-22	-20
	-2	-1	-7	-0	-0	-0	-0	-0	11	32	34	18
Net Cash Flow	-1	0	-0	0	0	-0	-0	0	1	-0	2	6
Free Cash Flow	1	0	6	-1	-2	0	-1	-2	-10	-32	-32	-11
CFO/OP	-56%	-53%	12,760%	9%	-24%	-3,456%	-40%	107%	-79%	-348%	-238%	54%

Ratios

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	187	272	124	47	21	47	31	21	135	126	99	92
Inventory Days	228	868	182	80	104	110	199	152	61	107	81	41
Days Payable	290	870	424	151	131	175	221	186	158	198	143	112
Cash Conversion Cycle	124	271	-119	-24	-7	-19	9	-14	38	34	36	21
Working Capital Days	-139	-564	-319	-50	-20	-36	-1	-15	48	54	39	29
ROCE %	-11%	-8%	-6%	3%	7%	-8%	-29%	-12%	38%	11%	1%	16%

Insights

In beta

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Permanent Employees
count

x	x	xx	xx	xx	xx	xx	xx	xxx	xxx
					xxx	x,xxx	x,xxx			x,xxx
						xxx	xxx		x,xxx	x,xxx
									xx.xx	xx.xx
							x			xx
										xxx

Please log in to see hidden values.

Installed Production Capacity
TPA

Production Volume
MT

Export Sales as % of Total Revenue
%

Number of Export Countries
count

Number of Customers (Consumers and Traders)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

5 Recently

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Jul 2026
	53.89%	53.89%	53.89%	53.17%	53.17%	57.02%	56.71%	56.71%	56.71%	60.86%	60.15%	63.38%
	0.14%	0.25%	0.25%	0.20%	0.20%	0.18%	0.18%	0.18%	0.18%	0.16%	0.16%	0.15%
	45.97%	45.86%	45.87%	46.63%	46.63%	42.79%	43.11%	43.11%	43.11%	38.97%	39.70%	36.47%
No. of Shareholders	12,571	13,942	13,310	13,305	13,445	13,223	12,906	13,273	12,836	12,855	12,809	12,825

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jul 2026
	24.40%	23.56%	23.59%	10.50%	9.54%	16.34%	53.82%	53.89%	57.02%	60.86%	63.38%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.25%	0.18%	0.16%	0.15%
	75.60%	76.44%	76.41%	89.50%	90.46%	83.66%	46.19%	45.86%	42.79%	38.97%	36.47%
No. of Shareholders	8,793	8,288	8,146	7,994	7,903	8,396	10,181	13,942	13,223	12,855	12,825

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Concalls

Aug 2026

Transcript

AI Summary
PPT
May 2026

Transcript

AI Summary
PPT
Feb 2026

Transcript

AI Summary
PPT
Aug 2025

Transcript

AI Summary
PPT
May 2025

Transcript

AI Summary
PPT
May 2023

Transcript

AI Summary
PPT
Nov 2022

Transcript

AI Summary
PPT
Jul 2022

Transcript

AI Summary
PPT